These agents include semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and tirzepatide (Mounjaro, Zepbound), which also targets the glucose-dependent insulinotropic polypeptide (GIP) receptor
Due to the severe cognitive impairment of AD patients, their treatment and care require substantial economic and financial support, causing serious damage to global economic development (3)
This recycling system sustains intracellular antioxidant capacity and redox equilibrium
Topical Use Safety Profile Studies report minimal side effects, though mild irritation may occur in sensitive individuals
It can be used for oral, topical, or injectable applications, depending on the formulation and regulatory needs
Retrieved from Harris, E